VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $205,328,000 | -96.4% | 1,565 | -96.6% | 0.04% | -96.2% |
| Q2 2014 | $5,733,415,000 | -4.5% | 45,460 | -0.2% | 1.11% | -14.9% |
| Q1 2014 | $6,003,538,000 | -35.9% | 45,540 | -42.9% | 1.30% | -36.7% |
| Q4 2013 | $9,361,006,000 | +6.7% | 79,736 | -5.2% | 2.06% | -2.0% |
| Q3 2013 | $8,773,736,000 | +20.6% | 84,096 | -0.5% | 2.10% | +7.2% |
| Q2 2013 | $7,274,707,000 | – | 84,511 | – | 1.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |